For example, SNHG17 has been found to be significantly higher in breast cancer, colorectal cancer, gastric cancer, and prostate cancer (Zhang et al., 2019; Du et al., 2020; Liu et al., 2020a; Zhao et al., 2021). Here, SNHG17 is linked to breast cancer.